Lucio Gordan, MD

Articles

August 11th 2022

Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies

Natasha Khrystolubova, BPharm, RPh, BCOP Ray Bailey, RPh Roger Orr, PharmD, BCOP Lucio Gordan, MD Trista Auger, RPhT, CPhT

August 11th 2022

A Call to Action: Oncology Practices—and Patients—Need Performance Measures for Managing Oral Therapies

Natasha Khrystolubova, BPharm, RPh, BCOP Ray Bailey, RPh Roger Orr, PharmD, BCOP Lucio Gordan, MD Trista Auger, RPhT, CPhT

March 14th 2022

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Debra Patt, MD, PhD, MBA Lucio Gordan, MD Kashyap Patel, MD Ted Okon, MBA Nicolas Ferreyros, BA Nathan Markward, PhD, MPH Milena Sullivan, MA Blair Burnett, BA Brook Getachew, BA Crystal Harris, MPH

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.

June 21st 2021

Observations Regarding the Average Sales Price Reimbursement Methodology

Susan Weidner, MBA, MS Michael Diaz, MD Cass Schaedig Lucio Gordan, MD

June 21st 2021

Weidner et al, Appendices

Susan Weidner, MBA, MS Michael Diaz, MD Cass Schaedig Lucio Gordan, MD

Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology

Community Oncology Practices Show Resilience in COVID-19

December 17th 2020

Impact of the COVID-19 Pandemic on Specialty Community Practices: An Oncology Perspective

Lucio Gordan, MD Susan Weidner, MS

The COVID-19 pandemic has impacted specialty practices generally and oncology practices especially have been resilient throughout the pandemic.

March 7th 2019

Cost Differential of Immuno-Oncology Therapy Delivered at Community Versus Hospital Clinics

Lucio Gordan, MD Marlo Blazer, PharmD, BCOP Vishal Saundankar, MS Denise Kazzaz Susan Weidner, MS Michael Eaddy, PharmD, PhD

Administration of immuno-oncology therapy for cancer diagnoses in the community clinic setting is associated with lower costs compared with administration in a hospital-based clinic setting.

August 29th 2018

The Financial Impact of the Sequester Cut to Medicare Part B Drug Reimbursement in Community Oncology

Lucio Gordan, MD Cass Schaedig Susan Weidner, MBA, MS

August 22nd 2018

Survivorship Care Throughout the Cancer Journey

Don Champlain, MHA, RN Lucio Gordan, MD

Leaders at Florida Cancer Specialists discuss the cancer survivorship program they've created to meet the needs of their diverse population of patients.